We are an international consortium of physicians and researchers studying the causes of congenital hypogonadotropin hypogonadism affecting about 1 in 10,000 people and characterized by a delay or absent pubertal development. This condition results from GnRH deficiency and is frequently associated with the lack of a sense of smell (called Kallmann syndrome).
We are building a collaborative network of clinicians, clinical researchers, basic scientists, bioinformaticians, geneticists and patients in order to facilitate the translation of scientific discoveries into improved patient care. We are aiming to improve accessibility of expert medical care and advice for patients. We are also developing evaluation and treatment guidelines for GnRH deficiency, as well as educational materials for patients.
Our funding is from the European Cooperation in Science and Technology (COST).